Galvez, Dizon complete COVID-19 vaccine doses | Inquirer News

Galvez, Dizon complete COVID-19 vaccine doses

By: - Reporter / @KAguilarINQ
/ 04:23 PM April 06, 2021

MANILA, Philippines — National Task Force against COVID-19 officials Carlito Galvez Jr. and Vince Dizon said Tuesday they have both received their second doses of COVID-19 vaccine.

In an online Palace briefing, the two officials said they received their second dose last March 29.

“At nakita ko po medyo mas malakas po iyong side effects ng March 29, pero maganda po iyon sabi ng mga doktor kapag may side effects na parang inaantok ka at parang gusto mong matulog. Parang ang ibig sabihin, umiepekto po iyong vaccine,” said Galvez, the NTF chief implementer and the country’s vaccine czar.

ADVERTISEMENT

(I experienced stronger side effects when I was inoculated last March 29, but doctors said that it’s good to have side effects where you feel sleepy. They said it means the vaccine is taking effect.)

FEATURED STORIES

Dizon likewise said he experienced feeling sleepy after receiving his second dose of COVID-19 vaccine.

“Ako po’y nakatanggap na rin ng second dose ko noong March 29 sa Tala Hospital sa Caloocan. Meron konting antok lang pero wala nang ibang naramdaman since then,” Dizon said in the same briefing.

(I also received my second dose last March 29 at Tala Hospital in Caloocan. I only felt a little sleepy after that but I didn’t experience anything else since then.)

Both Galvez and Dizon first received the vaccine developed by China’s Sinovac on March 1 when the government launched its COVID-19 vaccination program.

As of April 3, the government already vaccinated 795,320 individuals against COVID-19.

JE
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: coronavirus Philippines, Vaccination, Vince Dizon

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.